George N Karageorge

Title: The Innovations of George N. Karageorge

Introduction

George N. Karageorge is a notable inventor based in Portland, Connecticut, with a remarkable portfolio of seven patents. His work primarily focuses on advancements in the field of biochemistry and pharmacology, contributing significantly to the development of therapeutic compounds.

Latest Patents

Among his latest patents, one is centered around Pyrrolotriazine kinase inhibitors. This patent discloses compounds that can inhibit AAK1 (adaptor associated kinase 1), along with compositions comprising such compounds and methods for their application. Another significant patent involves Selective NR2B antagonists, which relates to compounds of a specific formula, including their salts. These compounds serve as ligands and antagonists of the NR2B receptor, potentially offering treatment options for various disorders of the central nervous system.

Career Highlights

George N. Karageorge has made substantial contributions to the pharmaceutical industry through his work at Bristol-Myers Squibb Company. His innovative research and development efforts have positioned him as a key figure in the advancement of new therapeutic solutions.

Collaborations

Throughout his career, George has collaborated with esteemed colleagues, including John E. Macor and Katherine S. Takaki, who is a prominent woman in the field. These collaborations have fostered a dynamic environment for innovation and discovery.

Conclusion

George N. Karageorge's contributions to the field of biochemistry and pharmacology through his patents and collaborations highlight his significant role as an inventor. His work continues to pave the way for new therapeutic advancements that can benefit many.